Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA.
EMBO J. 2018 Dec 14;37(24). doi: 10.15252/embj.2018100409. Epub 2018 Nov 16.
A finely tuned balance of self-renewal, differentiation, proliferation, and survival governs the pool size and regenerative capacity of blood-forming hematopoietic stem and progenitor cells (HSPCs). Here, we report that protein kinase C delta (PKCδ) is a critical regulator of adult HSPC number and function that couples the proliferative and metabolic activities of HSPCs. PKCδ-deficient mice showed a pronounced increase in HSPC numbers, increased competence in reconstituting lethally irradiated recipients, enhanced long-term competitive advantage in serial transplantation studies, and an augmented HSPC recovery during stress. PKCδ-deficient HSPCs also showed accelerated proliferation and reduced apoptosis, but did not exhaust in serial transplant assays or induce leukemia. Using inducible knockout and transplantation models, we further found that PKCδ acts in a hematopoietic cell-intrinsic manner to restrict HSPC number and bone marrow regenerative function. Mechanistically, PKCδ regulates HSPC energy metabolism and coordinately governs multiple regulators within signaling pathways implicated in HSPC homeostasis. Together, these data identify PKCδ as a critical regulator of HSPC signaling and metabolism that acts to limit HSPC expansion in response to physiological and regenerative demands.
自我更新、分化、增殖和存活的精细平衡控制着造血干祖细胞(HSPC)的池大小和再生能力。在这里,我们报告蛋白激酶 C 德尔塔(PKCδ)是一个关键的调节因子,调节成年 HSPC 的数量和功能,它将 HSPC 的增殖和代谢活动联系起来。PKCδ 缺陷型小鼠表现出 HSPC 数量的明显增加,在致死性辐照受体重建中具有更高的能力,在连续移植研究中具有更强的长期竞争优势,以及在应激期间 HSPC 的恢复增强。PKCδ 缺陷型 HSPC 还表现出加速的增殖和减少的凋亡,但在连续移植试验中没有耗尽,也没有诱导白血病。使用诱导型敲除和移植模型,我们进一步发现 PKCδ 以造血细胞内在的方式发挥作用,限制 HSPC 的数量和骨髓再生功能。从机制上讲,PKCδ 调节 HSPC 的能量代谢,并协调调控与 HSPC 动态平衡相关的信号通路中的多个调节剂。总之,这些数据表明 PKCδ 是 HSPC 信号和代谢的关键调节因子,它可以响应生理和再生需求限制 HSPC 的扩增。